Structure–activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway
Inhibition of EGF-mediated ERK5 phosphorylation is examined for several 1-isopropyl-4-amino-6-ether linked benzimidazole-based compounds. In a prior communication we identified a novel class of benzimidazole-based inhibitors of EGF-induced phosphorylation of ERK5. In this paper we examine the biolog...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 18; no. 22; pp. 8054 - 8060 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Ltd
15.11.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Inhibition of EGF-mediated ERK5 phosphorylation is examined for several 1-isopropyl-4-amino-6-ether linked benzimidazole-based compounds.
In a prior communication we identified a novel class of benzimidazole-based inhibitors of EGF-induced phosphorylation of ERK5. In this paper we examine the biological activity of several 1-isopropyl-4-amino-6-ether linked benzimidazole-based compounds for their ability to selectively inhibit EGF-mediated ERK5 phosphorylation; potential utility of variation at the 6-position was indicated by the initial structural feature survey. Modification of EGF-induced formation of pERK1/2 and pERK5 in HEK293 cells were analyzed by Western blot analysis. Subsequent analysis of selected compounds in a high-throughput multiple kinase scan and the NCI 60-cell-line screen is presented. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2010.09.017 |